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Abstract
The Swedish-Norwegian Coldblooded trotter (CBT) is a local breed in Sweden and Norway
mainly used for harness racing. Previous studies have shown that a mutation from cytosine
(C) to adenine (A) in the doublesex and mab-3 related transcription factor 3 (DMRT3) gene
has a major impact on harness racing performance of different breeds. An association of the
DMRT3 mutation with early career performance has also been suggested. The aim of the cur-
rent study was to investigate this proposed association in a randomly selected group of CBTs.
769 CBTs (485 raced, 284 unraced) were genotyped for the DMRT3 mutation. The associa-
tion with racing performance was investigated for 13 performance traits and three different
age intervals: 3 years, 3 to 6 years, and 7 to 10 years of age, using the statistical software R.
Each performance trait was analyzed for association with DMRT3 using linear models. The
results suggest no association of the DMRT3 mutation with precocity (i.e. performance at 3
years of age). Only two traits (race time and number of disqualifications) were significantly dif-
ferent between the genotypes, with AA horses having the fastest times and CC horses having
the highest number of disqualifications at 3 years of age. The frequency of the AA genotype
was significantly lower in the raced CBT sample compared with the unraced sample and less
than 50% of the AA horses participated in a race. For the age intervals 3 to 6 and 7 to 10
years the AA horses also failed to demonstrate significantly better performance than the other
genotypes. Although suggested as the most favorable genotype for racing performance in
Standardbreds and Finnhorses across all ages, the AA genotype does not appear to be asso-
ciated with superior performance, early or late, in the racing career of CBTs.
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Introduction
Originating from North Swedish Draft horses and Norwegian Do¨le horses, the Coldblooded
trotter (CBT) is a local breed found in both Sweden and Norway. While traditionally used in
forest and agricultural work, the modern CBT is predominantly used in harness racing [1]. As
a result, modern CBT breeders tend to focus on producing fast, durable horses with good tem-
perament and conformation—as evidenced by the rapid improvement in harness racing per-
formance over the last century [2,3]. However, despite heavy selection for harness racing merit
within the breed, relatively little is known about the genes that underpin elite racing perfor-
mance in CBT. Therefore, the discovery that a nonsense mutation in the doublesex and mab-3
related transcription factor 3 (DMRT3) gene has a major influence on harness racing perfor-
mance was of great interest for the horse research community and the harness racing industry
[4].
In Standardbreds, a breed predominantly used for harness racing, the DMRT3 mutation
has been shown to be of great importance for the ability to trot at high speed, with the majority
of Standardbreds being homozygous for the mutation [4,5,6]. However, although Standard-
breds and CBTs are bred and selected for the same purpose, the frequency of the DMRT3
mutation was significantly lower in CBTs [5,6]. Moreover, the effect of the mutation was not
as obvious in CBT. Most notably, homozygous A CBTs were significantly more successful (i.e.
higher prize money earned) at 3 years of age, but as the horses matured the association weak-
ened [6]. By contrast, studies of both Standardbreds and Finnhorses, a Finnish CBT, clearly
demonstrated the superiority of AA horses for all traits regardless of age [6,7].
This juxtaposition regarding the superiority of AA horses is an important distinction to
make given its potential for significantly altering the genomic architecture of the CBT breed.
While not as extreme amongst CBT breeders compared to Thoroughbreds or Standardbreds,
the desire for a quick return on a horse is common across all racing breeds. The nature of the
industry, be it gallop or harness racing, tends to favor precocious horses that can not only start
competing, but also win, at a young age. The possible association between a single gene and
precocity could easily push the selection of CBT in one direction, reducing the genetic varia-
tion of an already limited population. With this in mind, the aim of the current study was to
investigate the suggested precociousness of AA horses, as well as the association between the
DMRT3 mutation and racing performance at older ages, in a randomly selected horse material.
Materials and methods
Sample collection
To ensure at least 475 raced horses (equivalent to five 96-well plates) and to accurately reflect
the proportion of raced and unraced horses in the population, a sample of 1000 registered
Swedish/Norwegian CBTs born between 2000–2009 were randomly selected from the database
of the Swedish- and the Norwegian Trotting Association, using the software program for sta-
tistical computing R [8]. Hair and blood samples were obtained for the first 770 horses listed
(485 raced, 285 unraced) from the Animal Genetics Laboratory at the Swedish University of
Agricultural Sciences, Uppsala, Sweden and the Norwegian University of Life Sciences, Oslo,
Norway. The study was approved by the Ethics Committee for Animal Experiments in Upp-
sala, Sweden (Number C121/14).
DNA extraction and SNP genotyping
DNA was isolated from hair roots using a standardized procedure. Five hair roots were cut
into separate wells in 96-well plate. A solution of 100 μl Chelex (5%) and 7 μl proteinase K was
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added to each well. The 96-well plates were incubated at 56˚C for 60 minutes and 95˚C for 10
minutes, to inactivate proteinase K. The DNA from blood samples was extracted from 350 μl
blood using the Qiasymphony instrument (Qiagen, Hilden, Germany).
The SNP genotyping of the DMRT3_Ser301STOP marker (ECA23:22,999,655) was per-
formed using the StepOnePlus Real-Time PCR System (Life Technologies) with custom-
designed TaqMan SNP Genotyping Assays (Applied Biosystems).
Performance data
Performance data for the years 2003–2015 was provided by the Swedish Trotting Association.
To investigate the effect of DMRT3 at different ages, three different age intervals were defined;
3 years, 3 to 6 years, and 7 to 10 years of age. The age interval 3 to 6 years was chosen as the
genetic evaluation of CBTs is based on performance results and racing status between the ages
3 to 6 years [9]. The following performance traits were analyzed:
Rankings: The number of victories was calculated as the total number of times a horse finished
a race in first place. The number of placings was calculated as the total number of times a
horse finished a race in first, second or third place. The number of unplaced was calculated
as the total number of times when a horse finished a race in fourth place or lower.
Racing times: Two different start methods were included in the study for the race times: auto-
and voltstart [1]. The best racing times for each horse were defined as the lowest time (in
seconds) per kilometer, for each start method.
Earnings: Earnings were calculated as the amount of prize money a horse had earned at each
age interval. The majority of the earnings provided were in Swedish currency (SEK), but
the earnings for Norwegian trotters were in Norwegian currency (NOK). In order to set all
earnings to Swedish currency an average exchange rate was calculated (μ = 0.95) for the
years 2003–2015 and multiplied with the Norwegian earnings [10]. Earnings per start were
calculated as the amount of prize money earned per start.
Disqualifications: The number of disqualifications was calculated as the total number of times
a horse was disqualified as a result of galloping or pacing during a race.
Estimated breeding values (EBVs): Estimated breeding values are based on the individual’s
results (40% racing status and 60% earnings for CBTs), as well as the relatives’ results. EBVs
are adjusted for the fixed effects of sex and age, and updated annually [9]. In this study, the
obtained EBVs were from 2015.
Statistical analysis
All statistical analyses were performed using R [8]. Hardy Weinberg equilibrium (HWE) was
evaluated using the R package “SNPassoc” [11]. Summary statistics for each performance traits
were calculated based on raw values. Each trait was tested for normality using the Shapiro-
Francia test. To get normally distributed values, the earnings and best racing times were trans-
formed according to a previously published formula: ln(earnings + 1 000) and ln(racing time–
68.2), respectively [12]. All other non-normally distributed traits were log10-transformed.
Horses with no time records using autostart or voltstart for respectively age interval were
excluded from all analyses concerning the corresponding starting method.
In order to determine the association of the DMRT3 genotype with performance, each trait
was analyzed using linear models. All models, except for those used for analysis of EBVs,
included fixed effects of sex, birthdate and country of registration. Covariates such as number
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of starts and earnings were included when applicable. A single marker association analysis was
performed using ANOVA. If the result was significant (P0.05), a multiple comparison test
was performed using Tukey’s HSD-test [13].
The difference in DMRT3 frequency between raced and unraced horses was analyzed using
a linear model including the fixed effects of sex, age and country of registration. The associa-
tion analyses were performed using ANOVA, followed by Tukey’s HSD-test.
Results
Population description
A total of 769 horses were successfully genotyped for the DMRT3 SNP. The distribution of
birth year and country of registration is presented in Fig 1.
The total sample consisted of 90 stallions, 332 geldings and 347 mares from 128 sires, with
an average of 6 offspring per sire. The number of offspring per sire ranged from 1 to 72. The
frequency of the AA genotype was significantly higher (P = 0.05) in the group of unraced
horses than in the group of raced horses (Fig 2). The genotypes for the raced and unraced
horses deviated significantly from HWE (P = 0.004 respectively P = 0.05), while the genotypes
for all horses combined (n = 769) did not deviate from HWE (P = 0.35). Fifty-five percent of
the raced horses started their first race at 3 years of age and there were no significant differ-
ences between the genotypes (Table 1). The average age for the first race was 3.8 years and it
did not differ between the genotypes (Table 1). The proportions of raced horses for each
genotype are presented in Fig 3. The descriptive performance results are presented in
S1 Table.
Fig 1. Distribution of birth year (n = 769).
https://doi.org/10.1371/journal.pone.0177351.g001
The association of the DMRT3 mutation with precocity in Coldblooded trotters
PLOS ONE | https://doi.org/10.1371/journal.pone.0177351 May 10, 2017 4 / 10
Fig 3. Percentage of raced horses for each DMRT3 genotype.
https://doi.org/10.1371/journal.pone.0177351.g003
Fig 2. DMRT3 genotype frequency in raced and unraced horses.
https://doi.org/10.1371/journal.pone.0177351.g002
Table 1. The percentage of raced Coldblooded trotters that started their first race at 3 years of age,
and the average age for the first start, presented for each DMRT3 genotype.
AA CA CC P-value1
Started at 3 years of age (%) 56 57 52 0.56
Average age for first race (years) 3.7 3.7 3.8 0.44
1A Kruskal-Wallis test was performed in R
https://doi.org/10.1371/journal.pone.0177351.t001
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Performance analysis
The fixed effects and covariates used in the linear models for each performance trait, including
P-values, are presented in S2 Table. While most of the performance analyses included all 485
raced horses, the analyses of disqualifications included only 350 horses. The remaining
(n = 135) horses were excluded due to insufficient availability of information pertaining to
disqualifications.
At 3 years of age, there were two significant differences between the genotypes; the race
time where the AA horses were significantly faster than the CC horses and the disqualifications
where the CC horses had the highest number (Table 2). For the age interval 3 to 6 years, the
CA horses performed significantly better than the CC horses for the majority of the traits.
Also, the AA horses had significantly more placings and fewer disqualifications than the CC
horses, but the lowest earnings (Table 3). At 7 to 10 years of age, the CA and CC horses had
significantly more starts than the AA horses. The AA horses also had the lowest number of pla-
cings and earnings. Additionally, the heterozygous horses had significantly better race times
compared to the other genotypes. The CC horses had the highest number of disqualifications
(Table 4). For a complete summary of the performance statistics for the different age classes,
see S3–S5 Tables. The average EBV of the raced horses was 108.5 and it did not differ between
genotypes (P>0.05).
Discussion
Although a previous study indicated a favorable association between the AA genotype for
DMRT3 and superior performance in young CBTs, the current study provides no evidence to
support such an association with DMRT3 [6]. The lack of concordance between the studies
may be due to the larger and randomly selected horse material used in the current study. Only
two significant differences (race time for voltstart and number of disqualifications) were found
Table 2. Mean and median racing performance results for Coldblooded trotters at 3 years of age according to DMRT3 genotype (n = 268).
Trait1 AA (n = 5–24) CA (n = 35–143) CC (n = 23–101) P-value2
Mean Median SE Mean Median SE Mean Median SE AA/CA CA/CC AA/CC
No. of starts 6.3 6.5 0.8 6.0 5.0 0.4 5.8 5.0 0.4 0.84 0.66 0.55
No. of victories 0.8 1.0 0.2 0.9 0 0.1 0.7 0 0.1 0.77 0.65 0.47
Victories (freq.) 0.088 0.079 0.019 0.101 0 0.015 0.083 0 0.015 0.99 0.66 0.94
No. of placings (1–3) 2.1 2.0 0.4 2.3 1 0.3 1.9 1.0 0.2 0.94 0.32 0.49
Placings (1–3) (freq.) 0.245 0.261 0.047 0.291 0.250 0.025 0.236 0.200 0.025 0.80 0.30 0.97
No. of unplaced 3.0 3.0 0.43 2.6 2.0 0 2.4 2.0 0.2 0.27 0.97 0.24
Unplaced (freq.) 0.563 0.506 0.07 0.481 0.500 0 0.497 0.500 0.033 0.48 0.91 0.65
No. of disqualifications3 0.5 0 0.2 0.6 0 0.1 1.1 1.0 0.2 0.86 0.02 0.09
Disqualifications (freq.)3 0.126 0 0.064 0.159 0 0.028 0.223 0.092 0.040 0.89 0.27 0.37
Earnings (SEK) 47 960 25 320 12 493 61 830 15 160 13 646 35 090 15 380 5 314 0.49 0.23 0.11
Earnings per start (SEK) 6 128 3 278 1 651 6 136 3 480 900 4 358 2 579 563 0.81 0.75 0.57
Race time autostart (sec/km)4 92.0 92.2 0.5 91.5 91.4 0.2 92.9 92.4 0.3 0.83 0.06 0.76
Race time voltstart (sec/km)5 94.6 94.0 0.9 95.8 95.1 0.4 96.0 95.4 0.4 0.09 0.82 0.05
1 Transformed values were used for the analysis: log10, ln(earnings + 1 000) and ln(race time—68.2)
2 A multiple comparison test was performed using Tukey´s HSD test. Significant results (P0.05) in bold
3 n = 176
4 n = 63
5 n = 245
https://doi.org/10.1371/journal.pone.0177351.t002
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Table 4. Mean and median racing performance results for Coldblooded trotters at 7 to 10 years of age according to DMRT3 genotype (n = 182).
Trait1 AA (n = 14–18) CA (n = 71–98) CC (n = 44–66) P-value2
Mean Median SE Mean Median SE Mean Median SE AA/CA CA/CC AA/CC
No. of starts 16.2 13.0 4.6 25.3 18.0 2.3 23.5 15.0 2.7 0.004 0.94 0.01
No. of victories 1.2 0 0.6 2.5 1.0 0.5 1.8 1.0 0.3 0.13 0.62 0.39
Victories (freq.) 0.048 0 0.016 0.074 0.043 0.010 0.067 0.046 0.011 0.51 0.89 0.71
No. of placings (1–3) 3.8 1.5 1.4 6.9 3.0 0.9 5.5 3.0 0.8 <0.001 0.38 0.02
Placings (1–3) (freq.) 0.174 0.141 0.042 0.211 0.200 0.017 0.186 0.189 0.017 0.59 0.66 0.90
No. of unplaced 10.0 6.5 3.0 14.0 10.5 1.0 12.0 9.0 1.4 0.005 0.10 0.16
Unplaced (freq.) 0.630 0.667 0 0.583 0.560 0 0.531 0.526 0.029 0.77 0.41 0.33
No. of disqualifications3 1.5 1.0 0.4 2.6 1.0 0.5 4.1 3.0 0.6 0.36 0.02 0.006
Disqualifications (freq.)3 0.120 0.056 0.041 0.178 0.101 0.032 0.269 0.233 0.035 0.68 0.12 0.09
Earnings (SEK) 62 120 23 020 26 265 168 200 53 900 33 435 114 000 40 140 28 748 0.004 0.20 0.10
Earnings per start (SEK) 2 903 2 402 556 4 371 3 283 513 3 328 2 482 465 1.00 0.71 0.85
Race time autostart (sec/km)4 89.7 89.6 0.6 87.7 87.7 0.3 89.1 88.8 0.4 0.006 0.007 0.54
Race time voltstart (sec/km)5 90.3 90.5 0.8 89.2 89.0 0.4 90.1 89.5 0.5 0.15 0.05 0.93
1 Transformed values were used for the analysis: log10, ln(earnings + 1 000) and ln(race time—68.2)
2 A multiple comparison test was performed using Tukey´s HSD test. Significant results (P0.05) in bold
3 n = 122
4 n = 129
5 n = 168
https://doi.org/10.1371/journal.pone.0177351.t004
Table 3. Mean and median racing performance results for Coldblooded trotters at 3 to 6 years of age according to DMRT3 genotype (n = 472).
Trait1 AA (n = 26–41) CA (n = 149–243) CC (n = 99–188) P-value2
Mean Median SE Mean Median SE Mean Median SE AA/CA CA/CC AA/CC
No. of starts 23.4 18.0 2.7 26.4 23.0 1.3 23.0 18.0 1.3 0.27 0.002 0.89
No. of victories 2.9 2.0 0.5 3.3 2.0 0.3 2.6 1.0 0.3 0.95 0.007 0.11
Victories (freq.) 0.126 0.111 0.020 0.111 0.080 0.008 0.088 0.054 0.008 0.68 0.11 0.13
No. of placings (1–3) 8.2 8.0 1.0 8.8 6.0 0.6 7.0 4.0 0.6 0.93 <0.001 0.007
Placings (1–3) (freq.) 0.323 0.329 0.031 0.298 0.286 0.013 0.243 0.225 0.014 0.70 0.005 0.03
No. of unplaced 11.0 7.0 1.5 12.0 11.0 0.6 11.0 9.0 0.6 0.31 0.004 0.93
Unplaced (freq.) 0.499 0.471 0.034 0.480 0.462 0.014 0.490 0.500 0.016 0.84 0.88 0.96
No. of disqualifications3 1.8 1.0 0.4 2.7 2.0 0.2 3.5 3.0 0.3 0.24 0.04 0.007
Disqualifications (freq.)3 0.111 0.043 0.024 0.142 0.100 0.013 0.229 0.188 0.019 0.65 <0.001 0.003
Earnings (SEK) 128 100 98 500 20 625 179 300 72 500 18 543 133 200 54 370 17 154 0.72 <0.001 0.03
Earnings/start (SEK) 4 963 3 895 594 5 417 3 781 428 4 178 2 873 355 1.00 0.007 0.19
Race time autostart (sec/km)4 89.1 88.9 0.4 89.5 88.8 0.5 89.9 89.8 0.3 0.76 0.002 0.39
Race time voltstart (sec/km)5 91.1 90.0 0.7 91.2 90.7 0.3 91.9 91.8 0.3 0.86 0.005 0.06
1 Transformed values were used for the analysis: log10, ln(earnings + 1 000) and ln(race time—68.2)
2 A multiple comparison test was performed using Tukey´s HSD test. Significant results (P0.05) in bold
3 n = 337
4 n = 275
5 n = 453
https://doi.org/10.1371/journal.pone.0177351.t003
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between the genotypes and traits associated with precocity (i.e. performance at 3 years of age)
(Table 2). Additionally, the proportion of AA horses that raced for the first time at 3 years of
age and the average age for the first race did not differ significantly from the other genotypes.
If AA horses were truly more precocious, a clear difference would be apparent, with a greater
proportion of AA horses racing at 3 years of age. As observed in Thoroughbreds where one
variant of the Myostatin gene is associated with early performance and sprinting ability [14], a
positive association of a specific genotype with precocity would likely result in a push towards
that genotype in the population. The fact that the majority of the CBTs are heterozygous for
the DMRT3 mutation, despite a desire for precocious horses, strongly suggests no significant
association between DMRT3 and precocity.
Perhaps a more interesting observation is the rather low proportion of raced AA horses
(Figs 2 and 3). As the ability to race is the most important factor for a successful racehorse, the
large proportion of unraced AA horses suggests a possible unfavorable association of the geno-
type with racing performance. While the genotypes for the whole population did not deviate
from HWE, the genotypes for the raced and unraced horses did deviate from HWE when ana-
lyzed separately. Given DMRT3s association with performance this may be an indicator of the
ongoing selection for racing performance in the CBTs. The AA horses that made it to the race-
track performed well up to six years of age, as indicated by high median values for earnings
and victories (Tables 2 and 3). Although successful at young ages, the AA horses did not per-
form as well for the older ages, where the median values for earnings and victories were the
lowest of the three genotypes (Table 4). Also, it is worth noticing that the AA horses had the
lowest number of starts for all ages except 3 years of age. This has also been seen in Finnhorses,
where the AA horses, despite the superior effect of the homozygous genotype, had the lowest
number of starts for all ages above four years of age [7]. Although the low number of starts for
AA Finnhorses may be explained by their superior performance, as successful racehorses tend
to compete less often, the low number of starts for both AA Finnhorses and CBTs may also
indicate an association between the AA genotype and poor durability.
Albeit still uncharted and possibly controversial, the disparate effect of the AA genotype on
performance in CBTs is potentially influenced by an increased preference of AA CBTs for the
gait pace [6]. Pacing in a race will lead to disqualification and therefore horses are prevented
from pacing by the use of different weights and shoes to balance the horse. Heavy balancing of
young horses could potentially increase the risk for injuries, which in turn may have a detri-
mental impact on performance. Although a potential reason for the low frequency of the AA
genotype in the CBT population, not all AA CBTs have a propensity for pace. Some AA horses
possess a conformation that makes them more prone to pace, but not all AA horses naturally
pace, as demonstrated in Icelandic horses [15]. Perhaps a similar occurrence is observed in
CBTs.
The CC CBTs in the current study were the least successful prior to six years of age, but
their performance improved as they matured (Table 4). CC CBTs reportedly display an infe-
rior trotting technique compared to the other genotypes [6], which is often indicative of a
horse that prefers to gallop rather than extend the trot when prompted for an increase in
speed. This is supported by the high frequency of the CC genotype in breeds traditionally used
for gallop races or recreation as well as the high numbers of disqualifications for the CC horses
in the current study [4,5,6]. Moreover, previous studies have demonstrated an unfavorable
association between the CC genotype and harness racing performance in other breeds [6,7,16].
While the exact reasons for this are unknown, it is possible that this poor performance is
rooted in a propensity to gallop. Despite this possible gait preference in CC CBTs, the fre-
quency of the CC genotype is still relatively high in the CBT population [5,6]. While CC
CBTs may posses a conformation better suited for galloping, the current study suggests that
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with time these horses can develop proper trotting technique and eventually become solid
racehorses.
Conclusion
The DMRT3 mutation does not appear to influence precocity in CBTs. However, the current
study suggests an association of DMRT3 genotype and the ability to start racing. As the effect
of the DMRT3 mutation in CBTs appears to be disparate from the effect seen in other harness
racing breeds, additional studies on CBTs would be beneficial to fully understand the influence
of the gene on harness racing performance.
Supporting information
S1 Table. Summary statistics of performance traits.
(DOCX)
S2 Table. P-values for fixed effects and covariates used in the models for estimation of per-
formance, at 3 years, 3 to 6 years, and 7 to 10 years of age.
(DOCX)
S3 Table. Descriptive performance results for 3 years of age stratified byDMRT3 genotype
(n = 268).
(DOCX)
S4 Table. Descriptive performance results for 3 to 6 years of age stratified byDMRT3 geno-
type (n = 472).
(DOCX)
S5 Table. Descriptive performance results for 7 to 10 years of age, stratified byDMRT3
genotype (n = 182).
(DOCX)
Acknowledgments
We want to thank Thorvaldur A´rnason and The Swedish Trotting Association for providing
the phenotype data.
Author Contributions
Conceptualization: KJF CFI ES GL BDV.
Data curation: KJF CL KP BDV.
Formal analysis: KJF CL BDV.
Funding acquisition: CO CFI ES GL.
Investigation: KJF CL KP MKJ MW BDV.
Methodology: KJF CL KP CFI ES GL BDV.
Project administration: KJF CFI ES GL BDV.
Resources: KHR CFI ES GL.
Software: KJF ES CFI GL BDV.
Supervision: KJF CFI ES GL BDV.
The association of the DMRT3 mutation with precocity in Coldblooded trotters
PLOS ONE | https://doi.org/10.1371/journal.pone.0177351 May 10, 2017 9 / 10
Validation: KJF CFI ES GL BDV.
Visualization: KJF CL BDV.
Writing – original draft: KJF CL BDV.
Writing – review & editing: KJF CL KP MKJ CO LA LSA KHR CFI ES GL BDV.
References
1. Thiruvenkadan AK, Kandasamy N, Panneerselvam S. Inheritance of racing performance of trotter
horses: An overview. Livest Sci, 2009; 124: 163–181.
2. The Swedish Trotting Association. Medelindex. 2012. https://www.travsport.se/polopoly_fs/1.356298!/
menu/standard/file/medelindex_svf_kb_76-12.pdf. Accessed December 14, 2016.
3. The Swedish Trotting Association. 5 Feb 2014. Avelsva¨rdering av kallblodiga hingstar. 2014. https://
www.travsport.se/artikel/avelsvardering_av_kallblod. Accessed December 14, 2016.
4. Andersson LS, Larhammar M, Memic F, Wootz H, Schwochow D, Rubin C-J, et al. Mutations in DMRT3
affect locomotion in horses and spinal circuit function in mice, Nature, 2012; 488: 642–646. https://doi.
org/10.1038/nature11399 PMID: 22932389
5. Promero´va M, Andersson LS, Juras R, Penedo CT, Reissmann M, Tozaki T, et al. Worldwide frequency
distribution of the ‘Gait keeper’ mutation in the DMRT3 gene. Anim Genet, 2014; 45: 274–282. https://
doi.org/10.1111/age.12120 PMID: 24444049
6. Ja¨derkvist K, Andersson LS, Johansson AM, A´ rnason T, Mikko S, Eriksson S, et al. The DMRT3 ‘Gait
keeper’ mutation affects performance of Nordic and Standardbred trotters. J Anim Sci, 2014; 92: 4279–
4286. https://doi.org/10.2527/jas.2014-7803 PMID: 25085403
7. Ja¨derkvist Fegraeus K, Johansson L, Ma¨enpa¨a¨ M, Mykka¨nen A, Andersson LS, Velie BD, et al. Differ-
ent DMRT3 genotypes are best adapted for harness racing and riding in Finnhorses. J Hered, 2015;
106: 734–740. https://doi.org/10.1093/jhered/esv062 PMID: 26285915
8. R Development Core Team. ‘R: A Language and Environment for Statistical Computing’, R Foundation
for Statistical Computing, Vienna Austria. 2011.
9. A´ rnason T. Genetic evaluation of Swedish standardbred trotters for racing performance traits and racing
status. J Anim Breed Genet, 1999; 116: 387–398.
10. Valuta. https://www.valuta.se. Accessed June 4 2016.
11. Gonza´lez JR, Armengol L, Sole´ X, Guı´no E, Mercader JM, Estivill X, et al. SNPassoc: an R package to
perform whole genome association studies. Bioinformatics, 2007; 23: 644–645. https://doi.org/10.1093/
bioinformatics/btm025 PMID: 17267436
12. A´ rnason T. The importance of different traits in genetic improvement of trotters. Proceedings of World
Congress on Genetics Applied to Livestock Production. University of Guelph, Guelph, Canada. August
7–12, 1994;17: 462–469.
13. Abdi H & Williams LJ. Tukey’s Honestly Significant Difference (HSD) Test. In: Salkind Neil (Ed.), Ency-
clopedia of Research Design. Thousand Oaks, CA: Sage. 2010.
14. Hill EW, Gu J, Eivers SS, Fonseca RG, McGivney BA, Govindarajan P, et al. A sequence polymorphism
in MSTN predicts sprinting ability and racing stamina in Thoroughbred horses. PLoS One, 2010; 5(1):
e8645. https://doi.org/10.1371/journal.pone.0008645 PMID: 20098749
15. Kristjansson T, Bjornsdottir S, Albertsdo´ttir E, Sigurdsson A, Pourcelot P, Crevier-Denoix N, et al. Asso-
ciation of conformation and riding ability in Icelandic horses. Livest Sci, 2016; 189: 91–101.
16. Ricard A. Does heterozygosity at the DMRT3 gene make French trotters better racers? Gen Sel Evol,
2015; 47: 10.
The association of the DMRT3 mutation with precocity in Coldblooded trotters
PLOS ONE | https://doi.org/10.1371/journal.pone.0177351 May 10, 2017 10 / 10
